Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

The human immune system recognizes neopeptides derived from mitochondrial DNA deletions.

Duvvuri B, Duvvuri VR, Wang C, Chen L, Wagar LE, Jamnik V, Wu J, Yeung RS, Grigull J, Watts TH, Wu GE.

J Immunol. 2014 May 15;192(10):4581-91. doi: 10.4049/jimmunol.1300774. Epub 2014 Apr 14.

2.

Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.

Abrams SI, Khleif SN, Bergmann-Leitner ES, Kantor JA, Chung Y, Hamilton JM, Schlom J.

Cell Immunol. 1997 Dec 15;182(2):137-51.

PMID:
9514698
3.

Experimental evidence that mutated-self peptides derived from mitochondrial DNA somatic mutations have the potential to trigger autoimmunity.

Chen L, Duvvuri B, Grigull J, Jamnik R, Wither JE, Wu GE.

Hum Immunol. 2014 Aug;75(8):873-9. doi: 10.1016/j.humimm.2014.06.012. Epub 2014 Jun 28.

PMID:
24979674
4.

CD4+ T-cell response to mitochondrial cytochrome B in human melanoma.

Voo KS, Zeng G, Mu JB, Zhou J, Su XZ, Wang RF.

Cancer Res. 2006 Jun 1;66(11):5919-26.

5.

Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.

Nilges K, Höhn H, Pilch H, Neukirch C, Freitag K, Talbot PJ, Maeurer MJ.

J Virol. 2003 May;77(9):5464-74.

6.

CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.

Stone JD, Stern LJ.

J Immunol. 2006 Feb 1;176(3):1498-505. Erratum in: J Immunol. 2006 Mar 15;176(6):3843.

8.

Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles.

Shams H, Klucar P, Weis SE, Lalvani A, Moonan PK, Safi H, Wizel B, Ewer K, Nepom GT, Lewinsohn DM, Andersen P, Barnes PF.

J Immunol. 2004 Aug 1;173(3):1966-77.

9.

Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.

Bae J, Martinson JA, Klingemann HG.

Clin Cancer Res. 2005 Feb 15;11(4):1629-38.

10.

Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells.

Corman JM, Sercarz EE, Nanda NK.

Clin Exp Immunol. 1998 Nov;114(2):166-72.

11.

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens.

Herr W, Schneider J, Lohse AW, Meyer zum Büschenfelde KH, Wölfel T.

J Immunol Methods. 1996 May 27;191(2):131-42.

PMID:
8666832
12.

CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells.

Myers CE, Hanavan P, Antwi K, Mahadevan D, Nadeem AJ, Cooke L, Scheck AC, Laughrey Z, Lake DF.

Cancer Immunol Immunother. 2011 Sep;60(9):1319-32. doi: 10.1007/s00262-011-1032-4. Epub 2011 May 29.

PMID:
21626031
13.

Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes.

Dangles V, Halberstam I, Scardino A, Choppin J, Wertheimer M, Richon S, Quelvennec E, Moirand R, Guillet JG, Kosmatopoulos K, Bellet D, Zeliszewski D.

Cancer Immunol Immunother. 2002 Feb;50(12):673-81. Epub 2001 Dec 12.

PMID:
11862419
14.

Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.

Jäger E, Salter R, Castelli C, Höhn H, Freitag K, Karbach J, Neukirch C, Necker A, Knuth A, Maeurer MJ.

J Immunol. 2002 Mar 15;168(6):2766-72.

15.
16.

Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease.

Amir AL, Hagedoorn RS, van Luxemburg-Heijs SA, Marijt EW, Kruisselbrink AB, Frederik Falkenburg JH, Heemskerk MH.

Biol Blood Marrow Transplant. 2012 Feb;18(2):210-9. doi: 10.1016/j.bbmt.2011.10.018. Epub 2011 Oct 19.

18.

Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.

Tsuchida T, Parker KC, Turner RV, McFarland HF, Coligan JE, Biddison WE.

Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10859-63. Erratum in: Proc Natl Acad Sci U S A 1995 Sep 26;92(20):9432.

19.

Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors.

Sotiropoulou PA, Perez SA, Voelter V, Echner H, Missitzis I, Tsavaris NB, Papamichail M, Baxevanis CN.

Cancer Immunol Immunother. 2003 Dec;52(12):771-9. Epub 2003 Sep 10.

PMID:
13680193
20.

Impact of orthologous melan-A peptide immunizations on the anti-self melan-A/HLA-A2 T cell cross-reactivity.

Colombetti S, Fagerberg T, Baumgärtner P, Chapatte L, Speiser DE, Rufer N, Michielin O, Lévy F.

J Immunol. 2006 Jun 1;176(11):6560-7.

Supplemental Content

Support Center